Researchers will quantify how horses adapt muscle function and limb and upper body movements to cope with lameness, providing a greater understanding of clinical signs that can guide assessment and earlier intervention.
Researchers will collect preliminary bench-top data on a novel oncolytic therapy for equine sarcoid tumors using a genetically modified virus that infects and breaks down cancer cells but not normal cells.
Researchers will investigate the effect of a commonly administered intravenous fluid, called hydroxyethyl starch, in horses undergoing surgery for colic, specifically looking at microcirculation, blood pressure and cardiac output.
Researchers will identify immune system genes associated with meningoencephalitis of unknown origin, a common inflammatory central nervous system disease in dog
Researchers will evaluate two types of rabies vaccines to determine any effect on the resistance to unrelated infectious and parasitic diseases, and if this effect differs between males and females.
Researchers will study the genetics of drug response variability in dogs as a first step toward developing a novel, drug sensitivity test to increase drug safety and efficacy for individual patients.
Researchers will investigate brain function, brain metabolism and gut microbiome in dogs to distinguish between epileptic seizures and an episodic movement disorder called paroxysmal dyskinesia – commonly mistaken for epileptic seizures – to improve diagnosis and appropriate treatment.